Developing Next-Generation Potentially Curative Enzyme Medicines for Patients with Serious Auto-Immune/Neurodegenerative Diseases & Cancer

To develop and commercialize best-in-class enzyme biopharmaceuticals that enable precise & multi-fold delivery of therapeutic cells to diseased tissues with maximum residence time and therapeutic potency, to cure and even prevent life-threatening cancers, serious auto-immune and neurodegenerative diseases.